Long-term safety and efficacy of pregabalin as treatment of painful diabetic neuropathy (DPN): Findings from open-label extension studies

被引：0
|
作者：
Freeman, Roy
D'Urso-Decruz, Edith
Murphy, T. Kevin
Emir, Birol
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A151 / A151
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Pregabalin in the Treatment of Patients With Painful Diabetic Peripheral Neuropathy and Pain on Walking
    Huffman, Cynthia
    Stacey, Brett R.
    Tuchman, Michael
    Burbridge, Claire
    Li, Chunming
    Parsons, Bruce
    Pauer, Lynne
    Scavone, Joseph M.
    Behar, Regina
    Yurkewicz, Lorraine
    CLINICAL JOURNAL OF PAIN, 2015, 31 (11): : 946 - 958
  • [42] Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
    Goemans, Nathalie M.
    Tulinius, Mar
    van den Hauwe, Marleen
    Kroksmark, Anna-Karin
    Buyse, Gunnar
    Wilson, Rosamund J.
    van Deutekom, Judith C.
    de Kimpe, Sjef J.
    Lourbakos, Afrodite
    Campion, Giles
    PLOS ONE, 2016, 11 (09):
  • [43] Plozasiran and Triglyceride Levels in Hypertriglyceridemia: Long-Term Efficacy and Safety Data From Subjects in an Open-Label Extension Trial
    Ballantyne, Christie
    Watts, Gerald
    Rosenson, Robert
    Vasas, Szilard
    Pall, Denes
    Clifton, Peter
    Nicholls, Stephen
    Azizad, Masoud
    Fu, Ran
    Muhsin, Maan
    Melquist, Stacey
    Hellawell, Jennifer
    Gaudet, Daniel
    CIRCULATION, 2024, 150
  • [44] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: results from the DAYBREAK open-label extension study
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Selmaj, K. W.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Janjua, A.
    Huang, V.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 548 - 549
  • [45] Long-term safety and antihypertensive efficacy of irbesartan: Pooled results of five open-label studies
    Littlejohn, T
    Saini, R
    Kassler-Taub, K
    Crysant, SG
    Marbury, T
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (08) : 1273 - 1295
  • [46] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [47] Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy
    Beydoun, S.
    Alarcon, F.
    Mangat, S.
    Wan, Y.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (04): : 284 - 288
  • [48] LONG-TERM SAFETY OF PREGABALIN TREATMENT IN PATIENTS WITH PARTIAL-ONSET SEIZURES: POOLED ANALYSIS OF SIX OPEN-LABEL CLINICAL STUDIES
    Schulze-Bonhage, A.
    Uthman, B.
    Bazil, C.
    Whalen, E.
    Leon, T.
    Emir, B.
    Benabou, R.
    EPILEPSIA, 2009, 50 : 201 - 201
  • [49] LONG TERM STUDY OF PREGABALIN FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER: A 1 YEAR OPEN-LABEL EXTENSION
    Montgomery, S.
    Prieto, R.
    Emir, B.
    Haswell, H.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [50] Efficacy and safety of long-term, open-label treatment with calcitriol in postmenopausal osteoporosis: A retrospective analysis
    Caniggia, A
    Nuti, R
    Martini, G
    Frediani, B
    Giovani, S
    Valenti, R
    Silvestri, G
    Matarazzo, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (11): : 857 - 868
12345